Body clock sensor in eye discovered

Article

Light sensors present in 2% of retinal cells relate to the body's internal clock and not to vision, according to research published in the journal PLoS ONE.

Light sensors present in 2% of retinal cells relate to the body’s internal clock and not to vision, according to research published in the journal PLoS ONE.

Satchin Panda of the Regulatory Biology Laboratory at the Salk Institute for Biological Studies in La Jolla, California, US and colleagues toxically removed melanopsin, which detects the presence and intensity of light, from the retinal sensors of nocturnal mice; these mice retained normal vision but were unable to adjust their body clocks, and therefore awoke earlier in the evening than mice whose melanopsin-containing sensors were intact. The researchers found that both mouse and human genomes contain this “extra” light sensor.

The results confirm those of a separate study reported earlier this year in the journal Nature.Investigators believe that the study findings may offer new options for the treatment of light-related mood and sleep disorders.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.